Pediatric and neonatal Staphylococcus aureus bacteremia: epidemiology, risk factors, and outcome

Robert E Burke1, Meira S Halpern, Ellen Jo Baron

  • 1Department of Internal Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.

Insights

Methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections in children increased significantly from 2001-2006. Children with MRSA bacteremia experienced worse outcomes, highlighting the need for improved prevention strategies.

Area of Science:

  • Pediatric Infectious Diseases
  • Bacteriology
  • Epidemiology

Background:

  • Staphylococcus aureus (S. aureus) bloodstream infections (BSI) are a significant concern in pediatric populations.
  • Understanding the evolving prevalence of methicillin-susceptible S. aureus (MSSA) and methicillin-resistant S. aureus (MRSA) is crucial for effective treatment and prevention.

Purpose of the Study:

  • To evaluate the impact of methicillin-resistant Staphylococcus aureus (MRSA) on the prevalence of S. aureus bloodstream infection (BSI) among children.
  • To identify risk factors and clinical outcomes associated with S. aureus BSI in pediatric patients.

Main Methods:

  • Retrospective analysis of demographic data, risk factors, and clinical outcomes.
  • Inclusion criteria: children (<18 years) with S. aureus bacteremia hospitalized between 2001-2006.
  • Data collected included S. aureus susceptibility, timing of infection, comorbidities, and patient disposition.

Main Results:

  • The prevalence of MRSA bacteremia per 10,000 hospitalizations increased from 4 (2001-2003) to 11 (2004-2006) (P=.015).
  • Hospital-onset S. aureus bacteremia was more prevalent in children younger than 1 year (excluding neonates) and increased with longer hospital stays.
  • Children with MRSA bacteremia had longer hospital stays, higher transfer rates, and increased mortality compared to those with MSSA bacteremia.

Conclusions:

  • This study documents the increasing prevalence of S. aureus bacteremia in children, particularly MRSA.
  • Populations at higher risk for S. aureus bacteremia, including neonates and Hispanic children, were identified.
  • Improved prevention methods are needed for children with healthcare-associated risk factors for S. aureus bacteremia.
Abstract

Related Concept Videos

Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...